Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from Clinicians
DOI: https://doi.org/10.2147/copd.s449659
2024-05-30
International Journal of COPD
Abstract:Orjola Shahaj, 1 Anne Meiwald, 1 Krishnan Puri Sudhir, 1 Rupert Gara-Adams, 1 Peter Wark, 2 Alexis Cazaux, 3 Abelardo Elizondo Rios, 4 Sergey N Avdeev, 5 Elisabeth J Adams 1 1 Aquarius Population Health, London, UK; 2 Respiratory and Sleep Medicine, John Hunter Hospital, New Castle, Australia; 3 Pulmonary and Respiratory Medicine, Universidad Nacional de Cordoba, Cordoba, Argentina; 4 Intensive Pneumology, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico; 5 Respiratory Medicine, Sechenov First Moscow State Medical University, Moscow, Russia Correspondence: Elisabeth J Adams, Aquarius Population Health, Unit 29 Tileyard Studios, London, N7 9AH, UK, Tel +44 207 993 2930, Email Purpose: Chronic obstructive pulmonary disease (COPD) poses a significant global health burden despite being largely preventable and treatable. Despite the availability of guidelines, COPD care remains suboptimal in many settings, including high-income countries (HICs) and upper-middle-income countries (UMICs), with varied approaches to diagnosis and management. This study aimed to identify common and unique barriers to COPD care across six countries (Australia, Spain, Taiwan, Argentina, Mexico, and Russia) to inform global policy initiatives for improved care. Methods: COPD care pathways were mapped for each country and supplemented with epidemiological, health-economic, and clinical data from a targeted literature review. Semi-structured interviews with 17 respiratory care clinicians were used to further validate the pathways and identify key barriers. Thematic content analysis was used to generate the themes. Results: Six themes were common in most HICs and UMICs: "Challenges in COPD diagnosis", "Strengthening the role of primary care", "Fragmented healthcare systems and coordination challenges", "Inadequate management of COPD exacerbations", "Limited access to specialized care" and, "Impact of underfinanced and overloaded healthcare systems". One theme, "Insurance coverage and reimbursement challenges", was more relevant for UMICs. HICs and UMICs differ in patient and healthcare provider awareness, primary care involvement, spirometry access, and availability of specialized care. Both face issues with healthcare fragmentation, guideline adherence, and COPD exacerbation management. In addition, UMICs also grapple with resource limitations and healthcare infrastructure challenges. Conclusion: Many challenges to COPD care are the same in both HICs and UMICs, underscoring the pervasive nature of these issues. While country-specific issues require customized solutions, there are untapped possibilities for implementing global respiratory strategies that support countries to manage COPD effectively. In addition to healthcare system-level initiatives, there is a crucial need for political prioritization of COPD to allocate the essential resources it requires. Keywords: COPD, barriers, qualitative research, healthcare systems, global policy Chronic obstructive pulmonary disease (COPD) is a respiratory condition characterized by irreversible airflow limitation and symptoms such as dyspnoea, cough, and sputum production. The development of COPD is influenced by both environmental and genetic factors, with smoking and air pollution being primary environmental contributors. 1 Genetic predispositions also play a crucial role, with various gene polymorphisms linked to increased risk or disease progression. 2 COPD most commonly affects older adults, with a notable increase in prevalence, morbidity, and mortality as age advances. 3 While COPD has traditionally been associated with men, its prevalence among women is growing due to rising smoking rates among women, occupational exposures, and possibly greater vulnerability of women's lungs to smoking and other environmental pollutants. 4 Despite being preventable and treatable, 5 according to the Global Burden of Disease Study, in 2019, COPD accounted for 3.3 million deaths globally. 6 COPD is already the third leading cause of death globally, which is seven years ahead of the World Health Organisation's (WHO) prediction of 2030. 7 By 2060, deaths from COPD are expected to rise to 5.4 million. 8 The highest age-standardized COPD prevalence is in high-income countries (HICs), where it persists as a significant public health issue due to the considerable healthcare, economic and societal burden. 6 It is also an important issue in upper-middle-income countries (UMICs), which are expected to experience an increasing disease burden as their economies grow and populations age.< -Abstract Truncated-
respiratory system